Substantial evidences suggest that type 2 diabetes (T2DM) is a multi-factorial disease with a strong genetic component. A list of genetic susceptibility loci in populations of European and Asian ancestry has been established in the literature. Little is known on the inter-ethnic contribution of such established functional polymorphic variants. We performed a case-control study to explore the genetic susceptibility of 16 selected
Manshu Song, Feifei Zhao, Longjin Ran, Mamatyusupu Dolikun, Lijuan Wu, Lijuan Ge, Hao Dong, Qing Gao, Yanchun Zhai, Ling Zhang, Yuxiang Yan, Fen Liu, Xinghua Yang, Xiuhua Guo, Youxin Wang, and Wei Wang This journal article is available at Research Online: https://ro.ecu.edu.au/ecuworkspost2013/698 Introduction Type 2 diabetes mellitus (T2DM) is a complex disease characterized by insulin resistance in peripheral tissues and dysregulated insulin secretion by pancreatic beta-cells (Banerjee et al., 2014) . Substantial evidences suggest that T2DM is a multi-factorial disease with a strong genetic component. High concordance rate obtained in monozygotic twins (96%) supports a substantial contribution of genetic factors to T2DM (Barnett et al., 1981; Newman et al., 1987) . Furthermore, 40% of first-degree relatives of T2DM patients develop diabetes as compared to 6% in the general population (KoÈbberling and Tillil, 1982) . The general estimates of heritability (h 2 ) of T2DM is 0.49 and the relative recurrence risk for a sib of an affected person (λs) to develop T2DM is 3.5 (Risch, 1990; Lander and Schork, 1994) .
Multiple genetic loci have been discovered as risk factors for T2DM, most of which were detected from genome-wide association studies (GWAS) in populations of European and Asian ancestry (Sladek et al., 2007; Scott et al., 2007; Zeggini et al., 2008; Ahlqvist et al., 2011; Saxena et al., 2007; Zeggini et al., 2008) , e.g., loci near cyclin-dependent kinase 5 (CDK5), regulatory subunit-associated protein 1-like 1 (CDKAL1) ( Saxena et al., 2007) , peroxisome proliferator-activated receptor gamma (PPARG) (Saxena et al., 2007) and juxtaposed with another zinc finger 1 (JAZF1) ( Zeggini et al., 2008) . Most of these loci are related to insulin secretion and beta-cell function, while a few are involved in insulin resistance (Ahlqvist et al., 2011; Billings and Florez, 2010) . To date, more than 40 genetic loci have been reported and reproduced to be associated with T2DM or glycemic traits in Caucasian and Asian populations (Ahlqvist et al., 2011) .
There are differences in the contribution of known SNPs in T2DM susceptibility genes among various ethnic populations (Klimentidis et al., 2011) . SNP rs7754840 in CDKAL1, identified as T2DM susceptibility locus in subjects from Finland and Sweden by GWAS (Saxena et al., 2007) was replicated in Korean (Lee et al., 2008) , Han Chinese (Hu et al., 2009) , Pima Indians (Rong et al., 2009) and Lebanese Arab (Nemr et al., 2012) , but showed inconsistent in risk allele frequencies and odds ratios (ORs) among these ethnic populations. SNP rs864745 in JAZF1 was associated with T2DM in European population (Zeggini et al., 2008) , whereas it was not found to be associated with T2DM in Chinese (Hu et al., 2009) . Therefore, studies in other ethnic populations could aid in determining population-specific risk variants for T2DM.
Uyghur population, settled in Xinjiang Uyghur autonomous region, northwestern frontier area of China, accounts for 46% of the population in Xinjiang (Han Chinese accounts for 40% and Kazak accounts for 7%). It is a population presenting a typical admixture of Eastern and Western anthropometric traits (Wang et al., 2003; Black et al., 2006) . Uyghurs are overwhelmingly Muslim, and have their own language, religious beliefs and lifestyles that are very different from either Han Chinese population or American/European populations. Take dietary style as an example, the Uyghur has a high dairy intake level (over 200g) with more flour and meat, and less bean, vegetable and fishery products compared with Han Chinese living in the same area (Zhai et al., 2007) .
The prevalence of diabetes in Uyghur was higher than other ethnic groups in Xinjiang.
Tao et al reported that the prevalence of T2DM was 8.16% in Uyghur, which was higher than 1.47% in Kazak population (Tao et al., 2008) . Awuti et al reported that the prevalence of T2DM for Uyghur adults was 9.5% (Awuti et al., 2012) . In addition, a cross-sectional study in Xinjiang found that 19.6% of Uyghur had diabetes, exceptionally higher than that in Han Chinese (9.1%) and Kazakh (7.3%) . 6.23% of the Uyghur adults over 35 years old had diabetes, while 3.65% of Kazak adults had diabetes . For children under 17 years old, 0.77% of the Uyghur suffered from impaired fasting glucose (IFG) and diabetes, and that was 0.1% in Kazak (Zhang et al., 2012) .
Up to date, there have been only two reports on association of genetics makers with T2DM in Uyghur. The G allele of adiponectin gene carriers with reduced plasma concentrations of adiponectin might be associated with insulin resistance in Uyghur . In addition, peroxisome proliferator-activated receptor (PPAR)-gamma Pro12Ala polymorphism might affect susceptibility to diabetes in Uyghur (Li et al., 2008) .
In this case-control study, we investigated the associations between 16 SNPs susceptibility loci and T2DM as well as the combined effects of the SNPs on the risk of T2DM in a Uyghur population.
Materials and Methods
Participants A sample of 102 Uyghur participants was recruited from Uyghur population at Hetian of Xinjiang, China, where Uyghur population was less affected by the recent migration of Han Chinese. Fifty one T2DM patients (25 men and 26 women, age: 54.1±7.9 years old) were recruited from the local hospital as the T2DM group. The control group without diabetes was comprised of 51 health check-up participants (23 men and 28 women, age: 55.9±9.9 years old).
Inclusion criteria for the T2DM group were: Participants were included if they 1) had the ability to provide written informed consent, 2) were aged more than 18 years, self-reported Uyghur ethnicity without intermarriage history with other ethnic groups within the latest three generations, 3) were diagnosed with diabetes by physicians according to 1999 World Health Organization (WHO) Criteria (fasting plasma glucose greater than or equal to 7.0mmol/l and/ or 2-h plasma glucose greater than or equal to 11.1mmol/l) (Alberti et al., 1998) , and 4) were diagnosis of T2DM from clinical records obtained from the patients' health care provider.
Inclusion criteria for the control group were: Participants were included if they 1) had the ability to provide written informed consent, 2) were aged more than 18 years, self-reported Uyghur ethnicity without intermarriage history with other ethnic groups within the latest three generations, 3) did not have a documented clinical diagnosis of diabetes or other metabolic diseases, and 4) were not taking glucose-lowering medications and had fasting and 2h glucose values below the diagnostic thresholds for diabetes.
Anthropometric measurements including weight, height and waist measurements were obtained using standardized techniques. The body mass index (BMI) was calculated by the formula weight (in kilograms)/height (in square meters). Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured with mercury sphygmomanometer. Peripheral blood samples of patients and controls were collected in EDTA-anti-coagulated tubes after an overnight fast. Plasma glucose concentrations were measured by the glucose oxidase-peroxidase method using commercial kits.
Serum total cholesterol, serum triglycerides, high-density lipoprotein cholesterol (HDL), Low-density lipoprotein cholesterol (LDL) and HbA1c were measured using standard methods (cholesterol oxidase-peroxidase-amidopyrine method, glycerol phosphate oxidase-peroxidase-amidopyrine method, enzymatic methods on a Hitachi 911 automated analyzer (Boehringer Mannheim, Mannheim, Germany), calculating by the Friedewald formula and determined by high-performance liquid chromatography, respectively).
The study was approved by the local community leaders and the ethics committee of the Capital Medical University, Beijing, China.
Selection of the candidate SNPs and genotyping
rs780094 (GCKR) and rs4607517 (GCK)) were selected for the following reasons.
Firstly, minor allele frequencies (MAF) of these selected SNPs were more than 0.05 in both HapMap CEU data and HapMap CHB data (http://hapmap.ncbi.nlm.nih.gov/). These SNPs were reported to be associated with T2DM in several GWAS results among European ancestry (Saxena et al., 2007; Zeggini et al., 2008; Voight et al., 2010; Dupuis et al., 2010) , while 13 of them (except for rs7578326 (IRS1), rs780094 (GCKR) and rs4607517 (GCK)) were also evaluated in Han Chinese population (Hu et al., 2009; Wen et al., 2010; Liu et al., 2011; Hu et al., 2010; Zhou et al., 2010) . IRS1, GCKR and GCK were selected based on their roles in insulin signaling pathway and Fisher's exact test was applied to the loci with a small number of alleles or genotypes (equal to or less than 5). Associations between SNPs and T2DM risks were assessed using odds ratios (ORs) with 95% confidence intervals (95% CIs) and P value derived from logistic regression adjusted for age and body mass index (BMI).
In addition, to evaluate the combined effects of the SNPs, cumulative scores of risk alleles were counted. Risk allele was defined as OR>1 based on the results of association analysis of candidate SNPs for T2DM. We considered an additive genetic model for each SNP, and assigned a score of 0, 1, or 2 to genotypes at the 16 loci, depending on whether subjects carried the wild-type allele or were heterozygous or homozygous for the risk allele. The count method assumed that each risk allele contributes equally and independently to the risk for T2DM. Association of cumulative risk allelic scores and T2DM were also assessed using ORs with 95% CIs and P value derived from logistic regression. The significant level was set at P < 0.05, and all the analysis was two-sided.
Results

Sample characteristics
Participants' characteristics are shown in 
Discussion
Variants in more than 40 loci were identified to be associated with T2DM in more than one population by GWAS results. Some variants were associated with T2DM in one ethnic group of subjects but not in others. SNPs in PPARG, CDKAL1, CDKN2A/B, SLC30A8, IGF2BP2, TCF7L2, ADRA2A, FADS1, DGKB, IGF1, CDC123/CAMK1D, TSPAN8 and JAZF1 were identified to be associated with T2DM in European population by GWAS (Saxena et al.,2007; Zeggini et al., 2008; Dupuis et al., 2010) .
These SNPs have been confirmed by multiple studies in various populations, such as Danes, Han Chinese and Japanese (Hu et al., 2009; Wen et al., 2010; Liu et al., 2011; Hu et al., 2010; Zhou et al., 2010; Grarup et al., 2008; Ohshige et al., 2011) .
Study findings
In this study, the associations of SNPs in 16 respective T2DM candidate genes were investigated in Uyghurs. The Uyghur participants were recruited from Uyghur population at Hetian of Xinjiang, China, where the Uyghur population is less affected by the recent migration of Han Chinese and keeps its traditional lifestyles for generations, with its own language, religious beliefs and marriage pattern (Black et al., 2006) . Therefore, the Uyghur would be an ideal population for the study of evaluating genetic susceptibility. To our knowledge, this was the first attempt that a cohort of SNPs in PPARG, CDKAL1, CDKN2A/B, SLC30A8, IGF2BP2, TCF7L2, ADRA2A, FADS1, DGKB, IGF1, CDC123/CAMK1D, TSPAN8, JAZF1, IRS1, GCKR and GCK were genotyped in Uyghur participants for T2DM susceptibility study.
CDKAL1 is one of the most significant diabetes susceptibility genes identified to date in various populations. Intronic CDKAL1 variants rs7754840 has been found to be associated with T2DM mainly due to impaired first-phase insulin release (Chistiakov et al., 2011; Stancakova et al., 2008) . SNPs rs7756992, rs10946398 and rs9465871 in CDKAL1 were also found to be associated with T2DM among European population, Pima Indian, Han Chinese and Korean population in previous studies (Lee et al., 2008; Hu et al., 2009; Rong et al., 2009; Steinthorsdottir et al., 2007; Dehwah et al., 2010) .
Our study has revealed that the C allele of rs7754840 of CDKAL1 was significantly associated with T2DM in Uyghur participants (P=0.014, adjusted for age and BMI).
The OR value of rs7754840 was 2.32, higher than that of Han Chinese (1.127) (Hu et al., 2009 ), Pima Indians (1.06) (Rong et al., 2009) and Lebanese Arab population (1.86) (Nemr et al., 2012) . T2DM patients had a higher CC genotype and lower GG genotype of CDKAL1 when compared with the control group (Chi-square: 17.448, P <0.001, Table 3 ). This result was compatible with a study among Korean population, in which the CC genotype was significant higher in T2DM patients than that in controls (Lee et al., 2008) .
Among the other loci examined in this study, SNP rs864745 in JAZF1 also showed the most significant association with T2DM in Uyghur (P=0.032, adjusted for age and BMI). SNP rs864745 resides in intron-1 of JAZF1 gene, encoding a transcriptional repressor of the nuclear receptor subfamily-2, group C, member-2 (NR2C2) gene (Nakajima et al., 2004) . The carriage of JAZF1 risk variants may lead to postnatal growth restriction mainly due to affecting pancreatic β-cell mass and function (Grarup et al., 2008) . The association between rs864745 and T2DM varied among populations.
SNP rs864745 was strongly associated with T2DM in European participants (P= 5.0×10 -14 ) (Zeggini et al., 2008) , whereas no significant association was observed in
Han Chinese (P>0.05) (Hu et al., 2009) and Japanese subjects (P>0.05) (Takeuchi et al., 2009) . In our study, the OR value of rs864745 (0.48) was lower than that in Caucasians (1.50) , Han Chinese population (1.05-1.09) (Hu et al., 2009; Zhou et al., 2010) and Pakistani population (1.16) (Rees et al., 2011) .
Frequency of the CC genotype of rs864745 (JAZF1) was lower in T2DM patients than that in control group ( (Zhai et al., 2007) . Then, the practice of endogamy in Uyghur population might also be a reason (Wang et al., 2003;  The previous studies reported that accumulative number of risk alleles may be associated with T2DM, even though these alleles were not observed to be statistically significances individually (Fontaine-Bisson et al., 2010; Yamakawa-Kobayashi et al., 2012) . We calculated the cumulative risk allelic scores of these 16 risk alleles to evaluate the combined effects of these 16 SNPs, and a significance association was observed between accumulative risk allelic scores and T2DM in the Uyghur population samples (P=0.007).
Study limitations
While this study provides valuable insight into the genetic difference of T2DM related loci in minority groups, it has some limitations. Firstly, the ideal sample size should be about 300 pairs for cases and controls when we initiated this study. No multiple comparisons were attempted due to the relative small sample size than we originally designed in this pilot study. The statistical power of rs7754840 was calculated to 95% at the significance of 0.05, and those of other SNPs were less than 80% (SAS Proc Power). Because the people of minority groups usually refuse to participate in some investigation studies. Combined with less participant rate, the blood sampling is a very hard practice in Xinjiang, a very remote area of the northwestern frontier part of China. These are preliminary findings and further case-control studies with large samples and multiple comparisons are warranted to provide a more definite explanation about the relationships between those SNPs and T2DM based on our observation. Secondly, the existence of the interaction between environmental factors (e.g., life style, dietary, climates) and the T2DM susceptibility loci is needed to be further validated in Uyghur population. Moreover, the important information on rare variants with stronger effects on T2DM could be revealed by the next-generation of whole genome sequencing when the technique routine could be available in not far future.
Conclusions and Future Outlook
This is the first study to evaluate genomic variation at 16 SNPs in respective T2DM
candidate genes for the Uyghur population compared with other ethnic groups. The SNP rs7754840 in CDKAL1, rs864745 in JAZF1 and rs35767 in IGF1 might serve as potential susceptibility loci for T2DM in Uyghurs. We suggest that a broader capture and study of the world populations, including those that are hitherto understudied or overlooked, are necessary for a comprehensive understanding of the genetic/genomic basis of T2DM. Additionally, plant OMICS research including those with traditional plants (Sahu et al., 2014) that offer potential novel therapeutics for T2DM could be usefully is combined with studies of T2DM genetics so as to inform future personalized medicine research, global health and society.
